Aptevo Therapeutics

APVONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.345 M

$4.18 +2.70%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$26.0M

Loss-making

Shares outstanding

1,181,725

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#458FibroBiologicsFBLG$6.50M
#459Apimeds Pharmaceuticals USAPUS$6.38M
#460Aptevo TherapeuticsAPVO$6.35M
#461Enveric BiosciencesENVB$6.24M
#462HCW BiologicsHCWB$6.19M

Where these numbers come from

Share counts and financials for Aptevo Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.